Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications

被引:0
作者
Nikhil Bassi
Gregg C. Fonarow
机构
[1] Geffen School of Medicine at UCLA,UCLA Division of Cardiology
[2] Ronald Reagan-UCLA Medical Center,Ahmanson
来源
Current Cardiology Reports | 2018年 / 20卷
关键词
Diabetes; Heart failure; SGLT2-inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 205 条
  • [1] Moss SE(1991)Cause-specific mortality in a population-based study of diabetes Am J Public Health 81 1158-1162
  • [2] Klein R(2014)Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored Lancet Diabetes Endocrinol 2 843-851
  • [3] Klein BE(1979)Diabetes and cardiovascular disease: the Framingham study JAMA 241 2035-2038
  • [4] McMurray JJV(2004)The incidence of congestive heart failure in type 2 diabetes Diabetes Care 27 1879-1884
  • [5] Gerstein HC(2001)Glycemic control and heart failure among adult patients with diabetes Circulation 103 2668-2673
  • [6] Holman RR(2004)Heart failure prevalence, incidence, and mortality in the elderly with diabetes Diabetes Care 27 699-703
  • [7] Pfeffer MA(2004)Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure JACC 43 771-777
  • [8] Kannel WB(2005)Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies Am J Cardiol 96 1530-1536
  • [9] McGee DL(2018)Cardiovascular disease and risk management: standards of medical care in diabetes-2018 Diabetes Care 41 S86-S104
  • [10] Nichols GA(2013)Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 369 145-154